The Drug Data Hiding Behind AI’s Next Protein-Model Advantage
A confidential industry data pool improved a protein model, suggesting governed data access—not just compute—could shape drug AI’s next edge.
Tag drug discovery
Revolutionizing Drug Discovery: The AdaptiveFlow Platform
AdaptiveFlow introduces a groundbreaking approach to ultralarge virtual screenings, enhancing drug discovery efficiency and scalability.
Mapping the Druggable CRBN Interactome: Insights from Molecular Glue Degraders
A recent study has unveiled a comprehensive mapping of the cereblon (CRBN) interactome, revealing over 200 potential drug targets for molecular glue degraders (MGDs).
Harnessing Chemical Principles to Advance AI in Drug Discovery
MIT's Connor Coley is pioneering the integration of artificial intelligence with chemical principles to enhance drug discovery processes, developing models that predict interactions and reactions of potential drug compounds.
Harnessing AI for Accelerated Therapeutic Drug Discovery
MIT's James Collins discusses the integration of AI in the development of novel antibiotics, highlighting collaborative efforts and recent breakthroughs.
